Group One Trading
LKFT

Group One Trading’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Group One Trading’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,400
Closed -$177K – 8029
2025
Q4 		$177K Sell
5,400
-300
-5% -$9.69K ﹤0.01% 4487
2025
Q3 		$197K Sell
5,700
-34,300
-86% -$1.1M ﹤0.01% 4679
2025
Q2 		$1.12M Buy
40,000
+28,600
+251% +$767K ﹤0.01% 2660
2025
Q1 		$286K Sell
11,400
-569,900
-98% -$14.4M ﹤0.01% 3656
2024
Q4 		$16M Buy
581,300
+115,200
+25% +$3.21M 0.04% 470
2024
Q3 		$13.4M Buy
466,100
+465,300
+58,163% +$12.7M 0.04% 451
2024
Q2 		$19.8K Sell
800
-1,400
-64% -$39.7K ﹤0.01% 5235
2024
Q1 		$70.8K Sell
2,200
-12,100
-85% -$450K ﹤0.01% 4428
2023
Q4 		$581K Buy
14,300
+14,100
+7,050% +$519K ﹤0.01% 2944
2023
Q3 		$6.91K Sell
200
-33,300
-99% -$1.3M ﹤0.01% 6544
2023
Q2 		$1.36M Buy
33,500
+20,800
+164% +$848K ﹤0.01% 2062
2023
Q1 		$491K Buy
12,700
+9,000
+243% +$370K ﹤0.01% 2793
2022
Q4 		$164K Buy
3,700
+400
+12% +$16.8K ﹤0.01% 4021
2022
Q3 		$141K Sell
3,300
-12,000
-78% -$615K ﹤0.01% 4464
2022
Q2 		$854K Sell
15,300
-59,100
-79% -$3.5M ﹤0.01% 2917
2022
Q1 		$4.61M Buy
74,400
+30,000
+68% +$1.84M ﹤0.01% 1612
2021
Q4 		$2.45M Sell
44,400
-17,200
-28% -$897K ﹤0.01% 2378
2021
Q3 		$3.24M Buy
61,600
+32,400
+111% +$1.92M ﹤0.01% 2154
2021
Q2 		$2.01M Sell
29,200
-20,900
-42% -$1.59M ﹤0.01% 2640
2021
Q1 		$3.86M Buy
50,100
+11,500
+30% +$1.06M 0.01% 1791
2020
Q4 		$3.82M Buy
38,600
+15,800
+69% +$1.93M 0.01% 1496
2020
Q3 		$3.24M Sell
22,800
-5,900
-21% -$984K 0.01% 1215
2020
Q2 		$5.66M Buy
28,700
+9,100
+46% +$1.88M 0.03% 728
2020
Q1 		$3.84M Buy
19,600
+1,800
+10% +$387K 0.03% 672
2019
Q4 		$3.68M Buy
17,800
+5,700
+47% +$1.05M 0.03% 874
2019
Q3 		$1.85M Sell
12,100
-24,900
-67% -$4.08M 0.01% 1267
2019
Q2 		$4.77M Sell
37,000
-3,600
-9% -$427K 0.04% 545
2019
Q1 		$4.78M Buy
40,600
+36,600
+915% +$3.69M 0.05% 448
2018
Q4 		$367K Hold
4,000
– – ﹤0.01% 2208
2018
Q3 		$450K Buy
+4,000
New +$423K ﹤0.01% 2372

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
DCM
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Group One Trading's LKFT Position: Q2 2026 in Review

Group One Trading increased its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 246% in Q2 2026, buying an estimated $355K and bringing the position to 17,577 shares worth $527K. The position accounts for ﹤0.01% of the portfolio, ranked #3449.

Group One Trading first reported a position in LKFT in Q3 2018 and has held it in 25 quarters since. The position peaked at $4.83M in Q1 2020. 76 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

  • Group One Trading held 17,577 shares of Lakefront Biotherapeutics American Depositary Shares worth $527K as of Q2 2026.
  • Group One Trading bought 12,495 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $355K.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #3449 holding.
  • Group One Trading first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2018 and has held it in 25 quarters since.
  • Group One Trading's Lakefront Biotherapeutics American Depositary Shares position peaked at $4.83M in Q1 2020.
  • 76 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.